EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
   2.7.1.191 | Intellectual Disability |
22048657 |
A family-based association study of DIO2 and children mental retardation in the Qinba region of China. |
causal interaction
unassigned |
3
0 |
| 2.7.1.191 | Severe Acute Respiratory Syndrome |
33903831 |
A Fatal Extrapulmonary Manifestation of COVID-19. |
therapeutic application
unassigned |
1
0 |
| 2.7.1.191 | COVID-19 |
32851645 |
Angiotensin-converting enzyme II expression and its implication in the association between COVID-19 and allergic rhinitis. |
causal interaction
unassigned |
4
0 |
| 2.7.1.191 | Rhinitis, Allergic |
32851645 |
Angiotensin-converting enzyme II expression and its implication in the association between COVID-19 and allergic rhinitis. |
causal interaction
unassigned |
4
0 |
| 2.7.1.191 | Heart Failure |
31833870 |
Bioanalytical Assessment of Plasma Concentrations of Angiotensin-Converting Enzyme II Inhibitors and Angiotensin Receptor Blockers: A Pilot Study Among Patients Hospitalized With Acute Heart Failure. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
2
3
3
2 |
| 2.7.1.191 | COVID-19 |
33118327 |
Biophysical analysis of SARS-CoV-2 transmission and theranostic development via N protein computational characterization. |
causal interaction
unassigned |
3
0 |
| 2.7.1.191 | Pneumonia, Viral |
33118327 |
Biophysical analysis of SARS-CoV-2 transmission and theranostic development via N protein computational characterization. |
causal interaction
unassigned |
3
0 |
| 2.7.1.191 | Virus Diseases |
33118327 |
Biophysical analysis of SARS-CoV-2 transmission and theranostic development via N protein computational characterization. |
causal interaction
unassigned |
3
0 |
| 2.7.1.191 | Paraganglioma |
15066320 |
Chromosome 11 monosomy in conjunction with a mutated SDHD initiation codon in nonfamilial paraganglioma cases. |
causal interaction
unassigned |
1
0 |
| 2.7.1.191 | Severe Acute Respiratory Syndrome |
32538775 |
Combating sars-cov-2 through lipoxins, proteasome, caveolin and nuclear factor-?b pathways in non-pregnant and pregnant populations. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
